Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes

Thursday Jul 20, 2023
Thursday Jul 20, 2023
touchCLINICAL PERSPECTIVES for touchNEUROLOGY - Module 1 & 2
Module 1
Listen first to an expert provide their insights on the burden of migraine for patients, the need for effective preventive therapy and the currently available preventive treatment options.
The expert
Professor Simona Sacco - University of L’Aquila, Italy
Module 2
Listen next to a patient advocate providing her insights on the burden of migraine for patients and then to a clinical expert as he shares his perspectives on how real-world data for anti-CGRP antibodies can inform treatment optimization.
The patient advocate
Ms Elena Ruiz de la Torre - European Migraine & Headache Alliance, Spain
The clinical expert
Professor Mamoru Shibata - Ichikawa General Hospital, Chiba, Japan
- This touchPODCAST is for HCPs only.
- This activity is funded by an educational grant from Eli Lilly and Company Limited.
- This medical education is provided by touchIME.
For further information visit our website:
https://touchneurology.com/the-role-of-anti-CGRP-antibodies-in-migraine-prevention/

Tuesday Jul 18, 2023
Tuesday Jul 18, 2023
touchEXPERT OPINIONS for touchENDOCRINOLOGY
Leading experts share their insights on the role and use of radiopharmaceuticals in adult patients with solid tumours (with a focus on NETs and prostate cancer) and provide guidance for daily clinical practice to support their integration.
The experts:
Part 1 (00:00)
- Dr Stephen Graves, University of Iowa, Iowa City, IA, USA
- Dr Ana Kiess, Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA
Part 2 (20:20)
- Prof. Jorge Garcia, University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA
- Dr Jason Starr, Mayo Clinic, Jacksonville, FL, USA
- Dr Erik Mittra, Oregon Health and Science University, Portland, OR, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Advanced Accelerator Applications International S.A and is jointly provided by USF Health and touchIME.
For further information visit: https://touchendocrinologyime.org/radiopharmaceuticals-adult-oncology-primer/

Tuesday Jul 18, 2023
Tuesday Jul 18, 2023
touchEXPERT OPINIONS for touchONCOLOGY
Leading experts share their insights on the role and use of radiopharmaceuticals in adult patients with solid tumours (with a focus on NETs and prostate cancer) and provide guidance for daily clinical practice to support their integration.
The experts:
Part 1 (00:00)
- Dr Stephen Graves, University of Iowa, Iowa City, IA, USA
- Dr Ana Kiess, Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA
Part 2 (20:20)
- Prof. Jorge Garcia, University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA
- Dr Jason Starr, Mayo Clinic, Jacksonville, FL, USA
- Dr Erik Mittra, Oregon Health and Science University, Portland, OR, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Advanced Accelerator Applications International S.A and is jointly provided by USF Health and touchIME.
For further information visit: https://touchoncologyime.org/radiopharmaceuticals-adult-oncology-primer
Monday Jul 10, 2023
Monday Jul 10, 2023
Listen to a leading expert discuss the use of immune checkpoint inhibitors for the treatment of NSCLC, considering the current landscape and future perspectives.
The expert
- Dr Pilar Garrido – University Hospital Ramón y Cajal, Madrid, Spain
This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Merck and Co., Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
touchONCOLOGY
Monday Jul 10, 2023
Monday Jul 10, 2023
Listen to a leading expert discuss the use of immune checkpoint inhibitors for the treatment of NSCLC, considering the current landscape and future perspectives.
The expert
- Dr Pilar Garrido – University Hospital Ramón y Cajal, Madrid, Spain
This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Merck and Co., Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
touchRESPIRATORY
Thursday Jun 29, 2023
Shaping ART around individual needs: Maximizing adherence and quality of life
Thursday Jun 29, 2023
Thursday Jun 29, 2023
touchPANEL DISCUSSION for touchINFECTIOUS DISEASES
Listen to a panel of experts discuss the importance of optimizing antiretroviral therapy through an individualized approach to care and shared decision making.
The experts
- Prof Jens Lundgren, University of Copenhagen, Hvidovre, Denmark
- Prof Marta Boffito, Chelsea and Westminster Hospital and Imperial College London, UK
- Ms Angelina Namiba, 4M Network, UK
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Viiv Healthcare. This activity is provided by touchIME.
For further information visit:
https://touchinfectiousdiseases.com/
Thursday Jun 22, 2023
Thursday Jun 22, 2023
touchSATELLITE SYMPOSIUM for touchOPHTHALMOLOGY
Listen to this touch satellite symposium recorded live in June 2023 at the Annual Meeting of the Consortium of Multiple Sclerosis Centers.
Dr Dalia Rotstein (Canada), the chair for the symposium, is joined by Dr Eoin Flanagan (USA) and Dr Jeffrey Bennett (USA).
The first session, led by Dr Eoin Flanagan (03:55), focuses on the characterization of NMOSD, and the latest evidence-based strategies to achieve timely and accurate diagnosis. This is followed by audience Q&A (12:38).
The second session, led by Dr Jeffrey Bennett (15:57), discusses the latest efficacy and safety data on immunotherapies for NMOSD, and the factors influencing clinical decision making in daily practice. This is followed by audience Q&A (30:48).
In the third session, Dr Dalia Rotstein (34:49) summarizes the wider clinical symptoms of NMOSD and multidisciplinary strategies to mitigate the burden of disease. This is followed by a panel discussion in which the faculty provide their insights on selected Q&A from the audience (39:30).
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Alexion. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchophthalmologyime.org/nmosd-latest-developments/
Thursday Jun 22, 2023
Thursday Jun 22, 2023
touchSATELLITE SYMPOSIUM for touchNEUROLOGY
Listen to this touch satellite symposium recorded live in June 2023 at the Annual Meeting of the Consortium of Multiple Sclerosis Centers.
Dr Dalia Rotstein (Canada), the chair for the symposium, is joined by Dr Eoin Flanagan (USA) and Dr Jeffrey Bennett (USA).
The first session, led by Dr Eoin Flanagan (03:55), focuses on the characterization of NMOSD, and the latest evidence-based strategies to achieve timely and accurate diagnosis. This is followed by audience Q&A (12:38).
The second session, led by Dr Jeffrey Bennett (15:57), discusses the latest efficacy and safety data on immunotherapies for NMOSD, and the factors influencing clinical decision making in daily practice. This is followed by audience Q&A (30:48).
In the third session, Dr Dalia Rotstein (34:49) summarizes the wider clinical symptoms of NMOSD and multidisciplinary strategies to mitigate the burden of disease. This is followed by a panel discussion in which the faculty provide their insights on selected Q&A from the audience (39:30).
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Alexion. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurologyime.org/nmosd-latest-developments/

Wednesday Jun 21, 2023
Wednesday Jun 21, 2023
touchPANEL DISCUSSION for touchHAEMATOLOGY
Listen to a panel of leading experts discuss the key considerations for treatment selection and sequencing in patients with RRMM.
The experts:
- Dr Sarah Holstein, University of Nebraska Medical Center, Omaha, NE, USA
- Dr Nikhil Munshi, Dana-Farber Cancer Institute, Boston, MA, USA
- Dr Noopur Raje, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.
For further information please visit: https://touchhaematologyime.org/

Wednesday Jun 21, 2023
Wednesday Jun 21, 2023
touchPANEL DISCUSSION for touchONCOLOGY
Listen to a panel of leading experts discuss the key considerations for treatment selection and sequencing in patients with RRMM.
The experts:
- Dr Sarah Holstein, University of Nebraska Medical Center, Omaha, NE, USA
- Dr Nikhil Munshi, Dana-Farber Cancer Institute, Boston, MA, USA
- Dr Noopur Raje, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.
For further information please visit: https://touchoncology.com/
